Virus injection takes on Hard-to-Treat cancers

NCT ID NCT07128914

First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 15 times

Summary

This early-phase study tests a specially designed virus (GO306) that targets and kills cancer cells. It is for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and understand side effects. The virus is injected directly into the tumor or body cavity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fujian Cancer Hospital

    RECRUITING

    Fuzhou, Fujian, China

    Contact

  • Hunan Cancer Hospital

    RECRUITING

    Changsha, Hunan, China

    Contact

  • Shanghai General Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 201620, China

    Contact

    Contact

  • Shenzhen Third People's Hospital

    RECRUITING

    Shenzhen, Guangzhou, 518112, China

    Contact

  • The First Affiliated Hospital of Anhui Medical University

    RECRUITING

    Hefei, Anhui, China

    Contact

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, Henan, China

    Contact

Conditions

Explore the condition pages connected to this study.